Empagliflozin Treatment in Kidney Transplant Recipients
Conditions:   Kidney Transplant;   Type 2 Diabetes Intervention:   Drug: Empagliflozin Sponsors:   VA Office of Research and Development;   Iowa City VA Health Care System;   VA Pittsburgh Healthcare System;   Nashville VA Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials

Repurposing Empagliflozin and Dapagliflozin for Paediatric Heart Failure: Translational Approach and Dose Rationale
Condition:   Heart Failure Interventions:   Drug: Dapagliflozin tablet;   Drug: Empagliflozin Tablets Sponsors:   Centre Hospitalier Universitaire Vaudois;   Great Ormond Street Hospital for Children NHS Foundation Trust;   University College, London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials